ELAN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm

NEW YORK, NY / ACCESSWIRE / May 8, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/elan.

The investigation concerns whether Elanco and certain of its officers and/or directors have violated federal securities laws.

On May 7, 2020, Elanco reported its financial and operating results for the first quarter of 2020. For the quarter, Elanco reported GAAP earnings per share of -$0.12, missing consensus estimates by $0.18, and revenue of $657.7 million, missing consensus estimates by $62.49 million. Explaining the Company's disappointing results, Elanco's President and Chief Executive Officer cited, among other factors, "distributor performance" and stated that Elanco intended "to tighten our approach across many facets of our distributor relationships." On this news, Elanco's stock price fell $3.05 per share, or 13.3%, to close at $19.88 per share on May 7, 2020.

If you are aware of any facts relating to this investigation, or purchased Elanco shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/elan. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 589053